Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa
M Chitukuta, Z Duby, A Katz, T Nakyanzi… - Culture, health & …, 2019 - Taylor & Francis
Rumours may influence health-related behaviours, including the uptake of and adherence to
HIV prevention products. This study assessed the safety and effectiveness of a vaginal ring …
HIV prevention products. This study assessed the safety and effectiveness of a vaginal ring …
Impact of the dapivirine vaginal ring on sexual experiences and intimate partnerships of women in an HIV prevention clinical trial: managing ring detection and hot sex
Vaginally-inserted HIV prevention methods have been reported to impact the sexual
experience for women and their partners, and hence impacts acceptability of and adherence …
experience for women and their partners, and hence impacts acceptability of and adherence …
Does the ring work? Perceptions and understanding of the efficacy of a dapivirine vaginal ring for HIV prevention amongst women in a placebo-controlled trial
J Etima, AWK Katz, Z Duby, M Garcia… - AIDS and Behavior, 2022 - Springer
As demonstrated by the Phase III clinical trial, MTN-020/ASPIRE, the monthly dapivirine
vaginal ring is well tolerated and reduces the risk of HIV-1 as a woman-initiated prevention …
vaginal ring is well tolerated and reduces the risk of HIV-1 as a woman-initiated prevention …
Men's sexual experiences with the dapivirine vaginal ring in Malawi, South Africa, Uganda and Zimbabwe
ET Montgomery, AWK Katz, Z Duby, LE Mansoor… - AIDS and Behavior, 2021 - Springer
The dapivirine vaginal ring has been well-tolerated and shown to prevent HIV in clinical
trials. The ring is female initiated, yet endorsement for use is sought from male partners in …
trials. The ring is female initiated, yet endorsement for use is sought from male partners in …
Acceptability and use of a dapivirine vaginal ring in a phase III trial
ET Montgomery, A van der Straten, M Chitukuta… - Aids, 2017 - journals.lww.com
Background: The MTN-020/ASPIRE trial evaluated the safety and effectiveness of the
dapivirine vaginal ring for prevention of HIV-1 infection among African women. A nested …
dapivirine vaginal ring for prevention of HIV-1 infection among African women. A nested …
Characteristics of women enrolled into a randomized clinical trial of dapivirine vaginal ring for HIV-1 prevention
T Palanee-Phillips, K Schwartz, ER Brown… - PloS one, 2015 - journals.plos.org
Introduction Women in sub-Saharan Africa are a priority population for evaluation of new
biomedical HIV-1 prevention strategies. Antiretroviral pre-exposure prophylaxis is a …
biomedical HIV-1 prevention strategies. Antiretroviral pre-exposure prophylaxis is a …
Efficacy and action of the dapivirine vaginal ring as understood by women participating in an open label extension study
K Naidoo, AWK Katz, G Morgan, R Krishnaveni… - AIDS and Behavior, 2023 - Springer
The concept of efficacy, and how HIV prevention products biologically work can be complex.
We report on women's interpretation of efficacy of the dapivirine vaginal ring and how they …
We report on women's interpretation of efficacy of the dapivirine vaginal ring and how they …
Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women
A Nel, N van Niekerk, S Kapiga… - … England Journal of …, 2016 - Mass Medical Soc
Background The incidence of human immunodeficiency virus (HIV) infection remains high
among women in sub-Saharan Africa. We evaluated the safety and efficacy of extended use …
among women in sub-Saharan Africa. We evaluated the safety and efficacy of extended use …
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study
A Nel, N Van Niekerk, B Van Baelen, M Malherbe… - The Lancet …, 2021 - thelancet.com
Summary Background The Ring Study, a phase 3 trial in 1959 sexually active women
(randomised 2: 1), showed a favourable safety profile and a 31% HIV-1 infection risk …
(randomised 2: 1), showed a favourable safety profile and a 31% HIV-1 infection risk …
Hygiene, blood flow, and vaginal overload: why women removed an HIV prevention vaginal ring during menstruation in Malawi, South Africa, Uganda and Zimbabwe
We assessed the interference between vaginal ring use and menses among women who
participated in the qualitative component of the MTN-020/ASPIRE vaginal ring trial in …
participated in the qualitative component of the MTN-020/ASPIRE vaginal ring trial in …